All News #Library
Rare Diseases
Novo Nordisk Pens $2.1B Deal For Omeros` Stalled PNH Drug
15 Oct 2025 //
FIERCE BIOTECH
FDA Grants Rare Pediatric Disease Designation To Omeros’ Zaltenibart
24 Oct 2024 //
BUSINESSWIRE

Market Place
Sourcing Support